Quotient Sciences (“Quotient”), a leading drug development services and manufacturing organization, is pleased to announce that its Vice President of Pharmaceutical Sciences, Andy Lewis, has been appointed as Secretary of the Controlled Release Society (CRS).
CRS is the world’s leading scientific society, established to promote delivery science and technology, and is dedicated to the science of controlled release. The CRS serves members from more than 50 countries, with two-thirds of CRS membership representing industry and one-third representing academia and government.
Dr. Lewis has over 20 years of experience in the pharmaceutical and drug delivery industry. He currently leads a team of 120 scientists working on formulation development, clinical manufacturing, and pharmaceutical analysis projects. Dr Lewis is dedicated to overcoming drug delivery challenges, including solubility enhancement, controlled release, and transmucosal delivery of proteins and peptides. He is a member of the Academy of Pharmaceutical Scientists of Great Britain where he served on the Membership Committee and Board of Scientific Advisors, and for four years was Director-at-Large of the CRS.
Dr. Lewis will commence his service to the Controlled Release Society following the conclusion of the 2019 CRS Annual Meeting & Exposition held in Valencia, Spain, July 21-24, 2019.